Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

Schizophrenia usually starts in your late teens or young adulthood and is a lifelong condition. If you get catatonia, your episodes may come and go. But the right treatment will usually help ease ...

Globally, around 30% of individuals diagnosed with schizophrenia are treatment-resistant. This means they do not achieve remission of symptoms, such as hallucinations and delusions, despite treatment.

After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

Both psychosis and schizophrenia can lead to violence and self-harm, but these are not common symptoms, particularly among people who are receiving treatment. Although popular media often portrays ...

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of ...

Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control ...

Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with ...